Evan Norton, Director at NeuroPace Inc (NPCE), bought 588,235 shares at $17.00 ($10.0M) on 2021-04-21, disclosed to the SEC on 2021-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.